Citation only
via OpenAlex
Abstract TMP115: Common Transcriptomic and Biomarker Signatures in the Aging Brain and in Mendelian Neurovascular Disease, Cerebral Cavernous Malformation
Romuald Girard, Janne Koskimäki, Sean P. Polster, Yan Li, Dongdong Zhang, Sharbel G. Romanos, Julián Carrión‐Penagos, Agnieszka Stadnik, Rhonda Lightle, Thomas Moore, Sean B. Lyne, Nicholas Hobson, Ying Jun Cao, Abhinav Srinath, Robert Shenkar
Stroke · 2020
Abstract
Background: Cellular senescence(definition) is associated with gene expression dysregulation affecting endothelial barrier function as well as angiogenic and inflammatory processes. These pathological changes occur in cerebral cavernous malformations (CCMs), a neurovascular anomaly predisposing patients to hemorrhagic stroke. We hypothesize common transcriptomic and biomarker signatures between the aging brain and CCMs. Method: Brain specific genes dysregulate in Younger (age < 30) and Older (age > 50) human brain parenchyma were identified using the Genotype-Tissue Expression database, and compared with differential transcriptome in microdissected neurovascular units of human CCM lesions. Brain white matter vascular permeability in areas devoid of lesions was measured in non-CCM (23 Younger, 27 Older), Sporadic-CCM (S-CCM) (26 Younger, 37 Older) and Familial-CCM (F-CCM) (41 Younger, 17 Older) using dynamic contrast-enhanced quantitative perfusion MRI. Plasma levels of 6 proteins with reported roles in CCMs were quantified, including VEGF, angiopoietin (ANG 1 & 2), CRP, thrombospondin 2 (THBS 2), and endoglin (ENG). All reported correlations were significant at P< 0.05, FDR corrected. Result: We identified 320 genes (absolute fold change≥1.5) commonly dysregulated in aging brain and CCM, related to inflammation and extracellular matrix organization pathways. Brain permeability was greater in Older non-CCM and S-CCM compared to Younger subjects. Brain permeability was higher in Younger F-CCM harboring germ line CCM mutations, than in both Younger non-CCM (p<0.001) and S-CCM (p<0.05) lacking those mutations. No difference was observed in Younger or Older F-CCM and Older S-CCM or controls. Plasma levels of VEGF, ANG-2 and CRP were greater in both Older non-CCM and S-CCM compared to Younger. No difference was found in Older or Younger F-CCM. No differences were observed in THBS2, ENG and ANG1. Conclusion: There are common transcriptomic, and brain permeability and plasma biomarker signatures in the aging brain and CCM, suggesting common dysregulated pathways. Biomarkers and potential therapies identified in a well characterized Mendelian neurovascular disease may be applicable to mitigate the same mechanistic aberrations in the aging brain.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1161/str.51.suppl_1.tmp115
- Canonical
- link ↗
- Fetched
- 2026-11-16 MST
Cite this
APA
Girard, R., Koskimäki, J., Polster, S.P., Li, Y., Zhang, D., Romanos, S.G., Carrión‐Penagos, J., Stadnik, A., Lightle, R., Moore, T., Lyne, S.B., Hobson, N., Cao, Y.J., Srinath, A., Shenkar, R., Dimov, A., Carroll, T.J., Christoforidis, G.A., & Awad, I.A. (2020). Abstract TMP115: Common Transcriptomic and Biomarker Signatures in the Aging Brain and in Mendelian Neurovascular Disease, Cerebral Cavernous Malformation. <em>Stroke</em>. https://doi.org/10.1161/str.51.suppl_1.tmp115
Vancouver
Girard R, Koskimäki J, Polster SP, Li Y, Zhang D, Romanos SG, et al. Abstract TMP115: Common Transcriptomic and Biomarker Signatures in the Aging Brain and in Mendelian Neurovascular Disease, Cerebral Cavernous Malformation. Stroke. 2020. doi:10.1161/str.51.suppl_1.tmp115.
BibTeX
@article{romuald2020Abstra,
title = {Abstract TMP115: Common Transcriptomic and Biomarker Signatures in the Aging Brain and in Mendelian Neurovascular Disease, Cerebral Cavernous Malformation},
author = {Romuald Girard and Janne Koskimäki and Sean P. Polster and Yan Li and Dongdong Zhang and Sharbel G. Romanos and Julián Carrión‐Penagos and Agnieszka Stadnik and Rhonda Lightle and Thomas Moore and Sean B. Lyne and Nicholas Hobson and Ying Jun Cao and Abhinav Srinath and Robert Shenkar and Alexey Dimov and Timothy J. Carroll and Gregory A. Christoforidis and Issam A. Awad},
journal = {Stroke},
year = {2020},
doi = {10.1161/str.51.suppl_1.tmp115},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
bioRxiv (Cold Spring Harbor Laboratory) 2024
Preprint · CC-BY
Unravelling the Transcriptomic Symphony of Sarcopenia: Key Pathways and Hub Genes Altered by Muscle Ageing and Caloric Restriction Revealed by RNA Sequencing
medRxiv 2021
Preprint · OA
Single nuclei profiling identifies cell specific markers of skeletal muscle aging, sarcopenia and senescence
Innovation in Aging 2020
Open access · CC-BY
Aging Related Transcriptomic Changes in the Mouse Models of Alzheimer’s Disease
The journals of gerontology. Series A, Biological sciences and medical sciences 2026
Citation only
DNA methylation variability provides a complementary epigenetic signature of aging heterogeneity: Findings from the Canadian Longitudinal Study on Aging and the Baltimore Longitudinal Study of Aging.
BMC Genomics 2025
Open access · CC-BY
Unravelling the transcriptomic symphony of muscle ageing: key pathways and hub genes altered by ageing and caloric restriction in rat muscle revealed by RNA sequencing
The FASEB Journal 2022
Citation only